Skip to main content
. 2018 Feb 21;18:85. doi: 10.1186/s12879-018-2989-9

Table 3.

Outcome, indication, use and assessment of aminoglycosides in the group of patients with S. aureus endocarditis

Survivors (n = 20) Non survivors (n = 5) p
Indication of aminoglycosides 19/20 4/5 = 0.26
Delivery of aminoglycosides 15/20 2/5 = 0.12
Use of aminoglycosides in
Patients with indication
14/19 (73.6%) 1/4 (25%) = 0.07
Aminoglycosides conformity 14/20 (70%) 1/5 (20%) <  0.05